Table 2 Summarizes the baseline clinical characteristics of study population. [mean ± SEM].
ACHBLF (n = 46) | cHB (n = 46) | HC (n = 70) | |
|---|---|---|---|
Sex, Female/male | 22/24 | 26/20 | 36/34 |
Age (year) | 43.82 ± 9.89 | 39.4 ± 2.57 | 37.2 ± 2.36 |
HBsAg/HBeAg (+) | + | + | − |
HBV-DNA log10cps/mL | 1.27E + 005 | 3.8E + 006 | NA |
TBIL (mmol/L) | 291.08 ± 34.11 | 43.23 ± 3.57 | 13.84 ± 2.21 |
DBIL (mmol/L) | 180.45 ± 23.62 | 24.3 ± 1.82 | NA |
IBIL (mmol/L) | 95.76 ± 10.98 | 18.22 ± 3.41 | NA |
ALT (IU/mL) | 495.74 ± 140.75 | 124.43 ± 23.76 | NA |
AST (IU/mL) | 319.36 ± 40.02 | 111.39 ± 21.76 | NA |
TP (g/L) | 65.67 ± 3.15 | 68.69 ± 5.80 | NA |
ALB (g/L) | 34.32 ± 0.89 | 38.75 ± 5.90 | NA |
GLB (g/L) | 33.56 ± 1.36 | 29.68 ± 4.87 | NA |
PTA (%) | 31.2 ± 4.46 | 78.90 ± 9.08 | NA |
GGT (U/L) | 98.42 ± 8.91 | 67.90 ± 5.67 | NA |
ALP (IU/L) | 145.66 ± 15.86 | 89.90 ± 9.00 | NA |
AFP (ng/mL) | 198.08 ± 10.87 | 71.86 ± 7.98 | NA |
